Mid-Mortem Review
An independent on-site review of a China-related strategy, investment, or operating initiative already in progress, with findings delivered in a structured diagnostic report.
Diagnosis, not validation.
Some China-related business decisions look acceptable from a distance and very different on the ground.
A Mid-Mortem Review tests management's account of the initiative against operating reality, and names the mechanism producing any gap.
When To Use It
A China-related strategy, investment, or operating initiative is already in progress and underperforming
Management has lost a clear view of operating reality
A partner, team, or structure is not delivering as expected and the cause is unclear
Confidence in the initiative is weakening
What You Get
A structured PDF report with an executive conclusion, the key findings behind it, the cost of not acting, a recommended action, and a categorical decision.
The review includes a site visit, management interviews, and document review. Final report within 10 working days of completing the site visit. A 30–60 minute debrief call is included.
What It Is Not
This is not general advisory, remote commentary, or implementation support. It is a fixed-scope on-site review of a China-related initiative already in progress.
Pricing and Booking
Price: USD 6,500 + travel
If the initiative is already in progress, review it while corrective action is still possible.